PLEVKA, Pavel, Rushika PERERA, Moh Lan YAP, Jane CARDOSA, Richard KUHN and Michael G. ROSSMANN. Structure of human enterovirus 71 in complex with a capsid-binding inhibitor. Proceedings of the National Academy of Sciences of the United States of America. WASHINGTON: National Academy of Sciences, 2013, vol. 110, No 14, p. 5463-5467. ISSN 0027-8424. Available from: https://dx.doi.org/10.1073/pnas.1222379110.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Structure of human enterovirus 71 in complex with a capsid-binding inhibitor
Authors PLEVKA, Pavel, Rushika PERERA, Moh Lan YAP, Jane CARDOSA, Richard KUHN and Michael G. ROSSMANN.
Edition Proceedings of the National Academy of Sciences of the United States of America, WASHINGTON, National Academy of Sciences, 2013, 0027-8424.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10600 1.6 Biological sciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 9.809
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1073/pnas.1222379110
UT WoS 000318037800054
Keywords in English stability; virus
Tags neMU
Changed by Changed by: Mgr. Eva Špillingová, učo 110713. Changed: 29/3/2017 12:22.
Abstract
Human enterovirus 71 is a picornavirus causing hand, foot, and mouth disease that may progress to fatal encephalitis in infants and small children. As of now, no cure is available for enterovirus 71 infections. Small molecule inhibitors binding into a hydrophobic pocket within capsid viral protein 1 were previously shown to effectively limit infectivity of many picornaviruses. Here we report a 3.2-angstrom-resolution X-ray structure of the enterovirus 71 virion complexed with the capsid-binding inhibitor WIN 51711. The inhibitor replaced the natural pocket factor within the viral protein 1 pocket without inducing any detectable rearrangements in the structure of the capsid. Furthermore, we show that the compound stabilizes enterovirus 71 virions and limits its infectivity, probably through restricting dynamics of the capsid necessary for genome release. Thus, our results provide a structural basis for development of antienterovirus 71 capsid-binding drugs.
PrintDisplayed: 15/7/2024 21:56